The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.
NCT ID: NCT06666387
Last Updated: 2025-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-10-31
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The focus is on the evaluation of the diagnostic image quality in a clinical setting, considering the speed of the examination and the new functionalities to minimize the patient's lying times. Based on the assessment, the defined protocols and measurement sequences are further improved as necessary to optimize the clinical value of the sequences and user interface components.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618
Clinical Evaluation Of MP26 Features in Adults
NCT02927327
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NCT06232889
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881
Comparison of 18F FDG PET/CT TO PET MRI
NCT01986985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PET-MR examination
PET-MR examination
PET-MR examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET-MR examination
PET-MR examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Test subjects for whom a PET-CT examination is indicated and will be performed
* Test subjects of legal age who have given their written informed consent to participate in the clinical investigation
* Written consent of the test subject to be informed in the event of suspected clinically relevant incidental findings
* Written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality)
* The test subject´s written consent that the recorded image data may be made available to Siemens Healthcare A/S in pseudonymized form
* Test subjects whose weight does not exceed the permissible weight limit of the patient table (200 kg).
Exclusion Criteria
* All pacemakers and other implants
* Pregnancy: The exclusion of test subjects of childbearing potential is carried out based on a positive pregnancy test
* Test subjects who indicate an increased sensitivity to loud noises
* Test subjects who are incapable of giving consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siemens Healthcare A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Department of Clinical Physiology and Nuclear Medicine
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11723119-AVE-V02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.